Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment

E Sagnelli1, T Santantonio, N Coppola

  • 1Department of Mental Health and Public Medicine, Section of Infectious Diseases, Second University of Naples, via L. Armanni, No. 3, 80135, Naples, Italy, evangelista.sagnelli@unina2.it.

Infection
|March 13, 2014
PubMed

Insights

Early diagnosis of acute hepatitis C (AHC) is crucial for preventing chronic infection. Short-term interferon treatment can halt AHC progression in most cases, highlighting the importance of timely intervention.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Acute hepatitis C (AHC) is often asymptomatic, leading to delayed diagnosis and a high rate of progression to chronic infection.
  • Understanding risk factors and natural history is key to managing AHC effectively.

Purpose of the Study:

  • To review current literature on hepatitis C virus (HCV) transmission, diagnosis, natural history, and antiviral treatment of AHC.
  • To emphasize the clinical significance of early AHC diagnosis and treatment.

Main Methods:

  • Literature review of studies on AHC risk factors, diagnosis, natural history, and treatment.
  • Evaluation of diagnostic methods, including anti-HCV seroconversion and newer laboratory techniques.

Main Results:

  • Anti-HCV seroconversion is the gold standard for AHC diagnosis but is often uninformative due to unknown prior status.
  • Early, short-term interferon treatment effectively prevents chronicity in the majority of AHC patients.
  • Newer laboratory methods may help differentiate AHC from acute exacerbations of chronic HCV infection.

Conclusions:

  • Early diagnosis of AHC is clinically relevant, enabling prompt interferon treatment to prevent chronicity.
  • Developing and utilizing advanced laboratory diagnostics is recommended for accurate AHC identification.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
25
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
102
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
28
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382